Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens

Allergy. 2023 Jan;78(1):315-318. doi: 10.1111/all.15527. Epub 2022 Sep 28.

Authors

Sirikarn Jitthamstaporn¹, Rueangsit Inthong², Dittaya Audomsun³, Supapich Chanasit¹, Chanatip Thanasarnthungcharoen¹, Paulo J C Lin⁴, Drew Weissman⁵, Norbert Pardi^{5

6}, Alain Jacquet¹

Affiliations

¹ Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
³ Chulalongkorn University Systems Biology Center (CUSB), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
⁴ Acuitas Therapeutics, Vancouver, British Columbia, Canada.
⁵ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens
Animals
Antibody Formation
Antigens, Dermatophagoides
Dust
Humans
Hypersensitivity*
Nucleosides*
Pyroglyphidae

Substances

Nucleosides
Allergens
Antigens, Dermatophagoides
Dust